Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole plus Leuprolide for Adenomyosis
NCT03421639Phase 4Active, not recruiting
- Sponsor
- Centre for Endocrinology and Reproductive Medicine
- Start
- Dec 2017
- Primary completion
- Sep 2024
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 4 trial of anastrozole in adenomyosis, sponsored by Centre for Endocrinology and Reproductive Medicine. Started Dec 2017; status: active, not recruiting.
02
Drugs
anastrozole
03
Conditions
adenomyosis
Beyond the preview
Go deeper on NCT03421639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03421639.